Electronic Reporting Option

Sign up for monthly electronic reporting today. The process is quick and simple – a hyperlink is sent to you each month and no log-in and password are required.

Sign Up Now

ADR tips of the month

The “ADR Tip of the Month” is an educational tool on adverse drug reaction topics that is sent to participants on a monthly basis to build support and awareness of the Adverse Drug Reaction study, facilitating case ascertainment, and impacting new information relating to the study or broader ADR surveillance topics.

Health Canada may use this format to complement the ADR study by providing relevant, timely drug information.

Open
2011
Yasmin® and Yaz®
Open
2015
Winter brings cold and flu season
Open
2013
Why do surveillance for adverse drug reactions?
Open
2014
When should physicians seek referrals for ADRs?
Open
2005
Valproic acid (Depakene®, Epival®)
Open
2012
Valproate products – Risks to children when taken in pregnancy
Open
2014
Trends in CPSP ADR reporting 2004-2013
Open
2017
Tramadol
Open
2006
Topiramate (Topamax®) ‒ induced metabolic acidosis
Open
2010
Topical anesthetics-induced methemoglobinemia
Open
2013
Top 20 paediatric prescriptions in 2012
Open
2013
Top 10 paediatric prescriptions in 2010 and 2012
Open
2011
Top 10 paediatric prescriptions in 2010
Open
2014
The power of one
Open
2011
The importance of ADR reporting
Open
2009
Tamiflu™ – Possible side effects
Open
2008
Succinylcholine-induced major toxic effects
Open
2014
Stevens-Johnson syndrome
Open
2010
St. John’s Wort (Hypericum perforatum) – Benefits and risks
Open
2017
SOLU-MEDROL ACT-O-VIAL 40 mg - Risk of hypersensitivity in individuals allergic to cow's milk
Open
2012
Simethicone – Risk of interaction with levothyroxine
Open
2011
Serotonin toxicity
Open
2012
Second-generation antipsychotics – Cardiometabolic effects
Open
2016
Safety review of the HPV vaccine Gardasil
Open
2016
Safe medication storage
Open
2013
Risperidone – Risk of rhabdomyolysis
Open
2017
Risk of serious burns
Open
2015
Resources for physicians
Open
2015
Reporting reminder
Open
2009
Purple glove syndrome – Rare complication of intravenous phenytoin
Open
2012
Psychostimulants and hallucinations
Open
2014
Proton pump inhibitors: Risk of bone fractures
Open
2016
Propranolol for infants with hemangioma: Considerations
Open
2017
Phenytoin and fosphenytoin: Ineffective for oxin- and withdrawal-related seizures
Open
2012
Peanut oil-containing products
Open
2011
Oxybutin – Risk of CNS complications
Open
2013
Over-the-counter topical muscle and joint pain relievers – Risk of serious burns
Open
2013
Over-the-counter topical benzocaine gels and liquids – Risk of methemoblobinemia
Open
2013
Over-the-counter eye drops and nasal sprays – Risk of accidental ingestion by children
Open
2011
Over-the-counter drugs for colds
Open
2016
Over-the-counter acne medication
Open
2017
Ondansetron in Pregnancy
Open
2011
Olanzapine – Risk of oculogyric crisis
Open
2015
Nosodes – No alternative to vaccination
Open
2016
New safety measures for the prescription of codeine and hydrocodone in children
Open
2006
Neuroleptic malignant syndrome
Open
2006
Natural health products
Open
2014
Morning-after pill
Open
2010
Montelukast (Singulair™) – Risk of psychiatric adverse reactions
Open
2017
Misleading advertising of hCG for weight loss